Okomera secured €1.5 Million Grant

Okomera secured €1.5 Million Grant to Develop Microfluidics & AI Powered CRISPR Editing Platform for Target Validation !

Bpifrance is funding their novel CRISPR screening assay to accelerate drug discovery in oncology with leading cancer research center of Marseille, CRCM - Centre de Recherche en Cancérologie de Marseille !

➡️ Read more here

More news

Okomera secured €1.5 Million Grant

Okomera secured €1.5 Million Grant to Develop Microfluidics & AI Powered CRISPR Editing Platform for Target Validation ! Bpifrance is funding their...

Share this page Share on FacebookShare on TwitterShare on Linkedin